Author:
Magalhães Silva Tânia,Rebelo Gomes Eva,Ribeiro-Vaz Inês,Roque Fátima,Teresa Herdeiro Maria
Abstract
The World Health Organization (WHO) defines Pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse drug effects. The aim is to promote the safety and effective use of medicines through an early detection and evaluation of drug safety risks. The pharmacovigilance system is essentially based in spontaneous reports of Adverse Drug Reactions (ADR). ADR can be associated with severe outcomes and significant mortality, besides, most of them are deemed to be preventable events. Globally, antibiotics are among the most widely prescribed medications and their extensive use is linked to antibiotic-associated ADR. This chapter aims to summarize available epidemiological data concerning antibiotic use related ADR and analyze the reports received by the EudraVigilance system regarding the exclusive usage of antibiotics.
Reference61 articles.
1. Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol 2019; 51: 72-80.
2. World Health Organization. Antibiotic Resistance, https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance (2020, accessed 26 October 2020).
3. Fernandes P, Martens E. Antibiotics in late clinical development. Biochem Pharmacol 2017; 133: 152-163.
4. Sabtu N, Enoch DA, Brown NM. Antibiotic resistance: what, why, where, when and how? Br Med Bull 2015; ldv041.
5. Machowska A, Stålsby Lundborg C. Drivers of Irrational Use of Antibiotics in Europe. Int J Environ Res Public Health 2018; 16: 27.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献